ATE415469T1 - Verfahren zur gewinnung von heterologen polypeptiden aus bakterienzellen - Google Patents

Verfahren zur gewinnung von heterologen polypeptiden aus bakterienzellen

Info

Publication number
ATE415469T1
ATE415469T1 AT03006278T AT03006278T ATE415469T1 AT E415469 T1 ATE415469 T1 AT E415469T1 AT 03006278 T AT03006278 T AT 03006278T AT 03006278 T AT03006278 T AT 03006278T AT E415469 T1 ATE415469 T1 AT E415469T1
Authority
AT
Austria
Prior art keywords
nucleic acid
bacterial cells
polypeptides
acid encoding
heterologue
Prior art date
Application number
AT03006278T
Other languages
English (en)
Inventor
Woon-Lam Susan Leung
James R Swartz
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE415469T1 publication Critical patent/ATE415469T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54F(ab')2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10211Podoviridae
    • C12N2795/10222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10311Siphoviridae
    • C12N2795/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03006278T 1998-10-28 1999-10-21 Verfahren zur gewinnung von heterologen polypeptiden aus bakterienzellen ATE415469T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10605298P 1998-10-28 1998-10-28

Publications (1)

Publication Number Publication Date
ATE415469T1 true ATE415469T1 (de) 2008-12-15

Family

ID=22309219

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99971031T ATE250125T1 (de) 1998-10-28 1999-10-21 Verfahren zur gewinnung von heterologen polypeptiden aus bakterienzellen
AT03006278T ATE415469T1 (de) 1998-10-28 1999-10-21 Verfahren zur gewinnung von heterologen polypeptiden aus bakterienzellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99971031T ATE250125T1 (de) 1998-10-28 1999-10-21 Verfahren zur gewinnung von heterologen polypeptiden aus bakterienzellen

Country Status (13)

Country Link
US (2) US6180367B1 (de)
EP (2) EP1323820B1 (de)
JP (1) JP3711326B2 (de)
AT (2) ATE250125T1 (de)
AU (1) AU752429B2 (de)
CA (1) CA2346797C (de)
CY (1) CY1109847T1 (de)
DE (2) DE69911450T2 (de)
DK (2) DK1323820T3 (de)
ES (2) ES2318070T3 (de)
IL (2) IL142269A0 (de)
PT (2) PT1124941E (de)
WO (1) WO2000024873A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4298165B2 (ja) * 1998-03-30 2009-07-15 メタボリックス,インコーポレイテッド 生体適合材料の製造のための微生物株およびプロセス
US7858339B1 (en) 1998-10-28 2010-12-28 Genentech, Inc. Process for bacterial production of polypeptides
US6784558B2 (en) * 1999-12-30 2004-08-31 Intel Corporation Semiconductor device inlcluding optimized driver layout for integrated circuit with staggered bond pads
AU4305501A (en) * 1999-12-30 2001-07-16 Intel Corporation Optimized driver layout for integrated circuits with staggered bond pads
EP1427744B1 (de) 2001-08-27 2007-12-26 Genentech, Inc. System zur antikörperexpression und- synthese
US20030198682A1 (en) * 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7195611B1 (en) * 2002-12-31 2007-03-27 Advanced Cardiovascular Systems, Inc. Rapid exchange balloon catheter having a reinforced inner tubular member
WO2004081033A2 (en) * 2003-03-11 2004-09-23 National Institutes Of Health Synthesis of proteins by cell-free protein expression
US7985564B2 (en) 2003-11-21 2011-07-26 Pfenex, Inc. Expression systems with sec-system secretion
EP2412816B1 (de) 2004-07-26 2014-12-03 Pfenex Inc. Verfahren zur verbesserten Proteinexpression durch Strain-Engineering
AU2005280356B2 (en) 2004-08-16 2008-09-25 Clague P. Hodgson Improved strains of E. coli for plasmid DNA production
US20060156998A1 (en) * 2005-01-19 2006-07-20 Shawn Bridy Protective collar for animals
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents
AU2007272412B2 (en) 2006-07-14 2013-11-07 Genentech, Inc. Refolding of recombinant proteins
EP2089524B1 (de) * 2006-11-30 2012-10-10 Novozymes A/S Rekombinante wirtszellen der dnase-expression
EP2468869B1 (de) * 2007-01-31 2015-03-18 Pfenex Inc. Bakterielle Leader-Sequenzen für erhöhte Expression
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
EP2615172A1 (de) 2007-04-27 2013-07-17 Pfenex Inc. Schnellscreeningverfahren für Bakterienwirte zur Identifizierung bestimmter Stämme mit verbessertem Ertrag und/oder verbesserter Qualität bei der Expression heterologer Proteine
EP2160459A2 (de) * 2007-05-23 2010-03-10 Nature Technology Corp. Verbesserte e. coli-plasmid-dna-herstellung
US20110020830A1 (en) * 2008-03-31 2011-01-27 Schneider Jane C Design for rapidly cloning one or more polypeptide chains into an expression system
ES2370947B1 (es) * 2009-12-23 2012-11-02 Consejo Superior De Investigaciones Científicas (Csic) Sistema de autolisis celular para el procesado de la biomasa bacteriana en la produccion de polihidroxialcanoatos en pseudomonas putida kt2440
KR101222889B1 (ko) 2010-02-25 2013-01-17 고려대학교 산학협력단 이중프로모터를 포함하는 발현 시스템 및 그 시스템을 이용한 유전자 과다 발현 방법
JP6402347B2 (ja) * 2012-03-29 2018-10-10 株式会社シノテスト 核酸の検出又は定量方法及び検出又は定量用試薬キット
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
BR112015022181A8 (pt) 2013-03-12 2018-01-23 Massachusetts Eye & Ear Infirmary proteínas da substância de inibição mulleriana (mis) e usos das mesmas para o tratamento de doenças
CA2933335A1 (en) 2013-12-11 2015-06-18 The General Hospital Corporation Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation
EP3186379B1 (de) 2014-08-28 2020-04-08 Synthetic Biologics, Inc. Auf e. coli basierende herstellung von beta-lactamase
KR20190012145A (ko) * 2016-03-29 2019-02-08 젤터, 인코포레이티드 주변세포질 부피 대 세포질 부피의 비가 0.5:1 내지 10:1인 그람-음성 박테리아에서의 단백질의 발현
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
GB201814590D0 (en) * 2018-09-07 2018-10-24 Oxford Biomedica Ltd Viral vector production system
JP2022024197A (ja) * 2018-09-28 2022-02-09 Spiber株式会社 組換え細胞、組換え細胞の破砕方法及び目的タンパク質の製造方法
GB2597416A (en) 2019-04-12 2022-01-26 Geltor Inc Recombinant elastin and production thereof
EP4010500B1 (de) 2019-08-05 2025-02-19 Wacker Chemie AG Bakterienstamm zur freisetzung eines rekombinanten proteins in einem fermentationsverfahren
US20250197909A1 (en) * 2020-04-03 2025-06-19 Novozymes A/S Submerged fermentation process
EP3926039A1 (de) * 2020-06-17 2021-12-22 AB Enzymes GmbH Verwendung einer nuklease zur verringerung der viskosität und/oder zur verhinderung eines viskositätsanstiegs einer fermentationsbrühe
US20240352432A1 (en) * 2021-08-11 2024-10-24 Duke University Rapid expression and purification of thermostable proteins including taq polymerase
WO2024133316A1 (en) * 2022-12-23 2024-06-27 Thermo Fisher Scientific Baltics Uab Closed system for expressing recombinant proteins using e. coli and methods for producing clarified cell cultures thereof
CN118420716B (zh) * 2024-05-28 2025-10-31 青岛农业大学 一种多肽125、包含多肽125的生物材料及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595658A (en) 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
US4637980A (en) * 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
EP0155189A3 (de) * 1984-03-16 1987-09-16 Genentech, Inc. Expression eines die Zellwand degradierenden Proteins und für ein solches Protein kodierende DNS enthaltende Wirtszellen
DE3507648A1 (de) 1985-03-05 1986-09-11 Klöckner-Humboldt-Deutz AG, 5000 Köln Vorrichtung und verfahren zum warmhalten von fluessigen metallschmelzen
JPH0640832B2 (ja) 1985-05-10 1994-06-01 味の素株式会社 インタ−ロイキン2ポリペプチドの回収方法
SE8505027D0 (sv) * 1985-10-24 1985-10-24 Kabigen Ab A lytic virulent phage, a hostcell containing same and a process for protein production
US5169772A (en) 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
US5512456A (en) * 1990-05-25 1996-04-30 James Madison University Method for the improved production and recovery of poly-β-hydroxybutyrate from transformed Escherichia coli
RU2043415C1 (ru) 1992-02-18 1995-09-10 Биотехнологическая компания "Биосервис" ВЕКТОР PEL 5b, ПРЕДНАЗНАЧЕННЫЙ ДЛЯ ЭКСПРЕССИИ ЧУЖЕРОДНОЙ ДНК
RU2071501C1 (ru) 1992-02-18 1997-01-10 Биотехнологическая компания "Биосервис" Вектор реl25а, предназначенный для экспрессии чужеродного днк
RU2071503C1 (ru) 1992-02-18 1997-01-10 Биотехнологическая компания "Биосервис" ВЕКТОР pЕL5С, ПРЕДНАЗНАЧЕННЫЙ ДЛЯ ЭКСПРЕССИИ ЧУЖЕРОДНОЙ ДНК
AU5732694A (en) 1992-12-01 1994-06-22 Protein Design Labs, Inc. Humanized antibodies reactive with cd18

Also Published As

Publication number Publication date
EP1323820A3 (de) 2003-07-09
CA2346797C (en) 2008-09-23
CA2346797A1 (en) 2000-05-04
IL142269A (en) 2010-12-30
AU1219500A (en) 2000-05-15
DE69939991D1 (de) 2009-01-08
PT1323820E (pt) 2009-03-05
JP3711326B2 (ja) 2005-11-02
ATE250125T1 (de) 2003-10-15
IL142269A0 (en) 2002-03-10
ES2207340T3 (es) 2004-05-16
ES2318070T3 (es) 2009-05-01
AU752429B2 (en) 2002-09-19
JP2002528071A (ja) 2002-09-03
EP1323820A2 (de) 2003-07-02
EP1124941A1 (de) 2001-08-22
WO2000024873A1 (en) 2000-05-04
PT1124941E (pt) 2004-02-27
EP1124941B1 (de) 2003-09-17
DE69911450T2 (de) 2004-07-22
US6180367B1 (en) 2001-01-30
CY1109847T1 (el) 2014-09-10
WO2000024873A9 (en) 2000-11-02
DK1323820T3 (da) 2009-03-16
US6258560B1 (en) 2001-07-10
DK1124941T3 (da) 2004-02-02
EP1323820B1 (de) 2008-11-26
DE69911450D1 (de) 2003-10-23

Similar Documents

Publication Publication Date Title
DE69939991D1 (de) Verfahren zur Gewinnung von heterologen Polypeptiden aus Bakterienzellen
ATE299942T1 (de) Verfahren zur herstellung von natürlich gefalteten proteinen durch co-sekretion von molekularen chaperonen
WO1998023639A3 (en) Shk toxin compositions and methods of use
ATE318917T1 (de) Verfahren zur bakteriellen herstellung von heterologen polypeptiden mit disulfidbrücke
ATE317398T1 (de) Modifiziertes e.coli enterotoxin ii signalpeptid sowie ein mikroorganismus der ein fusionsprotein sowie ein heterologes protein exprimiert
EP2014770A3 (de) WNT-1-induziertes sekretiertes Polypeptid WISP-2
EE05008B1 (et) Meetod kiraalsete karboksüülhapete saamiseks nitriilidest nitrilaasi v?i mikroorganismide abil, missisaldavad ühte geeni nitrilaasi jaoks
MXPA01002592A (es) Polipeptidos de transmembrana y secretados y acidos nucleicos que codifican los mismos.
ATE81673T1 (de) Verfahren zur beseitigung von nendaminos|ureresten aus eukaryotpolypeptidanlagen und so erzeugte polypeptide.
WO2000036102A3 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
DK1616878T3 (da) Udskilte og membranspændende polypeptider samt nukleinsyrer kodende for disse
WO2005049644A3 (fr) Outil de transfert et de production de proteines mettant en oeuvre le systeme de secretion de type iii de pseudomonas
ATE409748T1 (de) Verfahren zur herstellung sekretorischer kex2- derivate
DE60037508D1 (de) Verfahren zur herstellung von rekombinantem insulin durch fusionsproteine
ATE415422T1 (de) Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren
Balganesh et al. Vector to produce biologically important peptides
DK0959130T3 (da) Kloning og udtrykkelse af nyt glucoamylasegen fra Endomyces fibuliger
EP1300417A3 (de) Sekretierte und transmembrane Polypeptide und dafür kodierende Nukleinsäuren
KR100514268B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
KR100514267B1 (en) Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same
ZA200103757B (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same.
EP1621619A3 (de) Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure
DK1247863T3 (da) Slangegiftprotein A-homolog og nukleinsyre kodende derfor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1323820

Country of ref document: EP